C18H25N5O3
Neat
359.43
-20°C
Room Temperature
Ethyl 3-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate, 2-Descyano-2-ethyl Formyl-tofacitinib, C6LBV2WY8D, 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)-beta-oxo-, ethyl ester, (3R, 4R)-, ethyl 3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate, 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo(2, 3-d)pyrimidin-4-ylamino)-beta-oxo-, ethyl ester, (3R, 4R)-, Ethyl (3R, 4R)-4-methyl-3-(methyl-7H-pyrrolo(2, 3-d)pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanoate, Ethyl (3R, 4R)-4-methyl-3-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanoate, Ethyl 3-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo(2, 3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate, UNII-C6LBV2WY8D, SCHEMBL23992222, ASC24818, CS-M3623, MFCD30537230, AKOS037650637, CS-15105, C13060, F790303, ethyl 3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanoate, Ethyl3-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
CCOC(=O)CC(=O)N1CC[C@H]([C@H](C1)N(C)C2=NC=NC3=C2C=CN3)C
ethyl 3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate
InChI=1S/C18H25N5O3/c1-4-26-16(25)9-15(24)23-8-6-12(2)14(10-23)22(3)18-13-5-7-19-17(13)20-11-21-18/h5,7,11-12,14H,4,6,8-10H2,1-3H3,(H,19,20,21)/t12-,14+/m1/s1